; however, they do not relapse from treatment owing to DTC dormancy. Understanding how the local microenvironment regulates the transition of DTCs from a quiescent state to active proliferation could suggest new therapeutic strategies to prevent or delay the formation of metastases. Here, we show that implantable biomaterial microenvironments incorporating human stromal cells, immune cells and cancer cells can be used to examine the post-dissemination phase of tumour microenvironment evolution. After subdermal implantation in mice, porous hydrogel scaffolds seeded with human bone marrow stromal cells form a vascularized niche and recruit human circulating tumour cells released from an orthotopic prostate tumour xenograft. Systemic injection of human peripheral blood mononuclear cells slowed the progression of early metastatic niches. However, the rate of overt metastases did not change. Implantable pre-metastatic niches provide a new opportunity to study DTC activation and evolution to lethal metastasis, and could facilitate the development of effective anti-metastatic therapies.
T umour cell dissemination and subsequent metastatic relapse is the leading cause of death from nearly all cancers. This insidious event has often already occurred when a patient is first diagnosed with a tumour. However, not all DTCs develop lethal metastases within the lifetime of the patient because the formation of aggressive secondary tumours is inefficient and lengthy 1 . Only a few circulating tumour cells (CTCs) disseminate successfully to vital organs, and the majority of these DTCs undergo apoptosis or clearance by immune cells 2 . Often, CTCs that survive extravasation do not immediately proliferate, but instead lay dormant for months to decades until the surrounding milieu becomes favourable for regrowth 3, 4 . Emerging evidence suggests that metastatic relapse may not be explained solely by the intrinsic genetic instability of DTCs; instead, bidirectional interaction with the surrounding microenvironment needs to be considered [5] [6] [7] . Understanding how the local milieu surrounding DTCs prevents or aids in regaining proliferative phenotypes is imperative to developing better therapeutic strategies to prevent or delay lethal metastasis.
CTCs theoretically spread to a wide range of distant organs, but metastasis limitedly occurs in a subset of target organs, including the lung, bone, liver and brain. This non-random development of metastasis has been recognized as the "Seed and Soil" hypothesis 8 . Recently, the "Pre-metastatic Niche" hypothesis further posits that CTCs are actively attracted to transiently formed pro-inflammatory microenvironments, driven by signalling from the primary tumour, in these distant organs that better support the survival and growth of DTCs 9 . The key microenvironmental signatures of the pre-metastatic niche include the following features: (1) a vascular network 10, 11 and associated oxygen tension (hypoxia) 12 ; (2) an altered local deposition of extracellular matrix components [13] [14] [15] ; (3) the recruitment of bone marrow-derived cells 9, 16 ; and (4) pro-inflammatory immune cell activity [17] [18] [19] [20] . These niche factors are believed to attract CTCs and subsequently direct the fate of DTCs to remain in a dormant state or to proliferate 21 . However, the detailed mechanisms through which dormant DTCs regain their aggressive phenotype while interacting with the local microenvironment have remained uncertain due to the lack of relevant experimental models that can faithfully simulate the post-dissemination phase of a dormant-to-active transition of DTCs with high analytical power.
Mouse models have been widely used to understand various aspects of cancer biology. For example, spontaneous and experimental metastasis models simulate invasion, circulation and dissemination of cells from solid tumours in a physiologically relevant manner [22] [23] [24] . The development of immunodeficient NOD-scid IL2Rg null (NSG) mice has improved the ability to study the biology of human cancer cells in the context of living systems 25 . This has greatly advanced knowledge about early-stage events in human tumour metastasis and the functional interplay between human DTCs and the local stromal microenvironment 26 . However, there are major limitations in current models to study the metastatic relapse of dormant human DTCs. First, experimental metastasis models always induce both active and dormant DTCs simultaneously, restricting the study of late-stage metastatic tumour recurrence. Second, rare dormant DTCs are impractical to detect. Metastatic relapse becomes evident only after reactivated DTCs establish a clinically detectable tumour mass. Third, immunodeficient mice cannot capture the role of the immune system in the microenvironmental regulation of DTC survival and outgrowth. Fourth, most of these mouse models rely on xenografts wherein human tumour cells interact with mouse stromal cells, which does not fully recapitulate human disease. Last, these systems offer little opportunity to manipulate individual properties of the niche, constraining the ability to distinguish the role of individual factors of the tumour microenvironment in regulating DTC biology.
Recently, tissue engineering strategies have been applied to address the fundamental limitations of conventional murine metastasis models [27] [28] [29] . These efforts can be divided into two different aspects based on the target tissues. Among the four major metastatic prone tissues, bone has been the most successful in tissue engineering. A combination of bone inducing biomaterial selection, porous scaffold design and osteogenic growth factors have successfully been applied to generate ectopic bone and marrow, mostly beneath the skin 30, 31 . The addition of human bone marrow stromal cell (hBMSC)-derived osteogenic cells and subsequently introduced human tumour cells recapitulate humanized bone-specific metastasis [32] [33] [34] [35] [36] . The second approach exploits the transient foreign body response triggered by biomaterials that attract immune cells along with CTCs to the site of implantation 26, [37] [38] [39] [40] . These approaches have been utilized to distinguish common biological processes that support aggressive metastatic tumour formation 26, 39 . Engineered tumour cell-attracting niches have also demonstrated translational potential, as they have been shown to significantly reduce the metastatic burden in vital organs and resultantly extend the lifespan of tumour-bearing mice [41] [42] [43] . However, tissue engineered microenvironments have not been applied for detailed investigations of the post-dissemination phase of cancer biology.
In this report, we introduce an experimental metastasis model to study the evolution of early humanized DTC niches in immunodeficient NSG mice. Functional pre-metastatic niches can arise in multiple tissue sites and share pro-inflammatory features observed during wound healing and tissue remodelling processes 44 . A recent study demonstrated that the repeated injection of tumour-derived exosomes induced a pre-metastatic niche in the liver and lung of mice 45 , indicating that a pre-metastatic niche can be generated by exogenously delivered factors. Based on this premise, we have developed a tissue engineered pre-metastatic niche by subdermally implanting inverted colloidal crystal (ICC) hydrogel scaffolds that induce vascularized and pro-inflammatory tissue microenvironments. This niche was humanized with hBMSCs pre-seeded on the scaffolds, followed by recruitment of CTCs released from an orthotopic human tumour xenograft. The established humanized premetastatic niche was applied to determine the long-term impact of inflammation triggered by human peripheral blood mononuclear cells (hPBMCs) on directing the fate of DTCs. Many patients with solid tumours suffering from metastasized lesions receive chemotherapy and/or radiation therapy and subsequent bone marrow transplantation. In these patients, graft-versus-tumour effects have been clinically observed, whereby grafted cells reduce the tumour burden of the recipient 46 . Therefore, we hypothesized that the introduction of hPBMCs would reduce long-term metastatic relapse by decreasing DTCs. Serial transplantation of early humanized DTC niches into syngeneic naive mice enabled prolonged evolution of the tumour microenvironments. Over a 10-week period, the kinetics of metastatic relapse were quantitatively monitored under whole-body bioluminescent imaging (BLI). At the end of the study, we identified early, intermediate and overt stages of the metastatic cascade. Deep multiplex imaging and quantitative analyses captured the ability of hPBMCs to reduce the number of single DTCs, but did not affect the incidence of overt metastatic tumour development. Additionally, the importance of the vasculature and innate immune cells in regulating the stable-to-active transition of human DTCs was substantiated. The presented tissue engineered, humanized and analytical niche model may serve as an enabling tool to study the microenvironmental regulation of the post-dissemination phase of cancer biology and the development of targets for anti-metastatic therapies.
Results

hBMSC-seeded ICC hydrogel scaffolds induce a vascularized tissue microenvironment in vivo.
We hypothesized that engineered implantable biomaterials could create pre-metastatic niche-mimicking tissue microenvironments by directing the foreign body response to promote angiogenesis and maintain a pro-inflammatory milieu. An isotropic porous ICC structure fabricated by a simple and tunable procedure was chosen to systematically investigate the role of biomaterial design in directing host tissue response by orthogonally manipulating its physical and chemical properties [47] [48] [49] [50] . The ICC geometry consists of fully interconnected spherical pore arrays and provides a maximal surface area in the given volume, increasing the biomaterial-tissue interface to direct the foreign body response 51 . The cavity diameter and mechanical integrity of the hydrogel matrix were recognized as important parameters to direct angiogenesis and subsequent systemic recruitment of cells, including immune and bone marrow cells. ICC scaffolds made with 5-50 wt% polyacrylamide hydrogel were subdermally implanted into immunodeficient NSG mice and retrieved 4 weeks later. There was no significant difference in tissue development from 30 to 50 wt%; however, scaffolds made with 5-15 wt% polyacrylamide mechanically collapsed after subdermal implantation and inter-scaffold tissue development was incomplete ( Supplementary Fig. 1 ). Next, 30 wt% polyacrylamide was examined in scaffolds with varying pore diameters from 75 to 500 µ m. Blood vessel diameters increased with increasing pore sizes, but larger pores (400-500 µ m) developed a more diverse range of vessels. Smaller pore sizes (75-150 µ m) induced relatively homogenous vascular development, but restricted stromal and immune cell migration ( Supplementary Fig. 2 ). Ultimately, we determined that a 6.5-mm diameter, 1-mm thick cylindrical ICC scaffold consisting of 300 ± 15 µ m pores with 30 wt% synthetic polyacrylamide hydrogel was optimal to generate a controlled humanized vascularized tissue at the subcutaneous site ( Fig. 1a) .
A humanized stromal niche was created by seeding 5 × 10 5 hBM-SCs onto an ICC hydrogel scaffold coated with type I collagen. hBMSCs are adherent fibroblastic cells isolated from the human bone marrow that carry multilineage capabilities and high secretory activity 52 ( Supplementary Fig. 3 ). Confocal imaging confirmed a deep and homogeneous distribution of hBMSCs, displaying a spindle-like cellular morphology ( Fig. 1b ). We previously demonstrated that subdermally implanted ICC scaffolds pre-seeded with hBM-SCs significantly enhanced vascularization and haematopoietic cell recruitment 37 . Four hBMSC scaffolds were implanted in the dorsal subcutaneous space apart from each other in NSG mice. ICC hydrogel scaffolds facilitated rapid and deep migration of mouse immune cells, which was in turn followed by near tissue cell migration and inter-scaffold angiogenesis. After 4 weeks, complete inter-scaffold tissue development was confirmed using scanning electron microscopy ( Supplementary Fig. 4 ). Histological analyses revealed that pores were filled with organized dense collagen extracellular matrix and populated with various types of haematopoietic cells on the pore surface ( Fig. 1c ). Immunohistostaining (IHS) for the mouse endothelial cell marker, mCD31 and the human mesenchymal marker, hVimentin revealed a richly vascularized tissue throughout the scaffold with hBMSCs ( Fig. 1d ). There was no overlap between mCD31 and hVimentin, indicating that blood vessels were mouse tissue derived and hBMSCs did not incorporate with mouse vessels. Inter-scaffold angiogenesis was directed by the biomaterial geometry as vasculature took on a branched morphology between the scaffold cavities ( Supplementary Fig. 5 ). A quantitative analysis revealed that most blood vessels and hBMSCs resided at the outer regions of the scaffold, gradually decreasing in number towards the centre (Fig. 1e,f ). This indicates that the survival of hBMSCs was dependent on the rapid formation of inter-scaffold blood vessels.
To determine whether engrafted hBMSCs remained functional, we examined the ex vivo secretion of cytokines from hBMSCs remaining in implanted scaffolds 4 and 12 weeks post implantation. Explanted scaffolds were cultured ex vivo for 36 h before conditioned media were collected and analysed for a subset of human cytokines (vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and IL-8) that have implicated importance in angiogenesis and inflammation 9,53-55 . Human cytokine secretion gradually diminished over time in vivo, but was still detectable by enzyme-linked immunosorbent assay (ELISA; > 35 pg ml -1 ) 12 weeks after implantation (Fig. 1g ). The directed foreign body response and hBMSC secretome in the ICC hydrogel scaffolds reproducibly form an analytical tissue microenvironment that recapitulates the three key features of premetastatic niche: vascular networks, bone marrow-derived cells and inflammatory immune cells.
Humanized stromal niches attract human CTCs and enable colonization. We employed an orthotopic xenograft tumour-based metastasis model with PC3 human prostate tumour cells, which has demonstrated robust engraftment and subsequent metastasis [56] [57] [58] . Three weeks after hBMSC scaffold implantation, we performed an intra-prostate injection of 2 × 10 6 PC3 human prostate tumour cells expressing enhanced green fluorescent protein (eGFP) and luciferase. Engraftment and metastatic spread of human tumour cells was non-invasively monitored via whole-body BLI. The efficiency of successful orthotopic engraftment based on BLI was above 90%. Unsuccessfully engrafted mice were excluded from experiments. BLI + mice were killed at 8 weeks because mice became moribund due to continuous growth of the primary tumour and aggressive metastasis in vital organs ( Fig. 2a) . A previous characterization demonstrated that by this time point, primary tumours grew in weight to ~400 mg and generated ~10-50 CTCs per ml of blood 26 . At the end of the study, gross examination of internal organs confirmed overt metastatic tumour nodules in the liver (Fig. 2b ). IHS of explanted tissues confirmed the formation of micrometastases in the liver and lung, whereas DTCs remained individually in the bone marrow and spleen ( Fig. 2c ). IHS of humanized stromal niches revealed CTCs had successfully disseminated. DTCs were mostly observed in a single cell state but there were few colonized DTCs (Fig. 2d ). These results verified that the implanted humanized stromal niches recapitulated the microenvironmental complexity, tumour cell attracting and supportive functions of the pre-metastatic niche.
Intravenously delivered hPBMCs increase human immune cell complexity. Immune cells, both innate and adaptive, are important components of the pre-metastatic niche 9, 59 . To add human immune cell complexity, we intravenously injected 1 × 10 7 hPBMCs isolated from healthy adult donors into mice bearing hBMSC scaffolds 4 weeks after implantation (Fig. 3a) . The initial distribution of hPBMCs was characterized 24 h after injection. As expected, hPBMCs were primarily localized to the spleen and lung. A relatively low and comparable level of hPBMCs was confirmed across hBMSC scaffolds, bone marrow and liver ( Fig. 3b ; Supplementary Fig. 6 ). At the same time point, we also determined whether systemically migrated immune cells initiated local tissue inflammation. After 36 h of ex vivo culture, conditioned media for human cytokines representative of inflammation (tumour necrosis factor-α (TNF-α ), IL-6 and IL-10) were compared to non-hPBMC-injected controls. Increased inflammatory cytokine secretion was observed in the lung, liver and spleen but not in the bone marrow. hBMSC scaffolds showed significantly increased pro-inflammatory IL-6 but decreased antiinflammatory IL-10 compared with hPBMC-free controls (Fig. 3c ). We then examined the long-term effect of human immune cells on tissues and hBMSC scaffolds by IHS for the pan-leukocyte marker hCD45 6 weeks after injection of hPBMCs. hCD45 + cells displayed a single cell morphology and were spread widely across the scaffold ( Fig. 3d ; Supplementary Fig. 7 ). Sublineage analysis of human immune cells confirmed that both hCD4 and hCD8 T lymphocytes were present in the scaffold ( Supplementary Fig. 8 ). Diffuse mCD31 endothelial staining in hPBMC-injected mice compared with controls indicated leaky and permeable vasculature, which is the representative vascular morphology in inflamed tissues 60 . Further quantitative image analyses confirmed a significant increase in vascular density in the scaffold tissue with hPBMCs compared with controls ( Fig. 3e ). Taken together, implantable humanized niches gained enhanced inflammatory characteristics after the introduction of hPBMCs. However, the host animals developed symptoms of systemic graft-versus-host-disease and became moribund 10-12 weeks post hPBMC injection 61, 62 .
Systemic delivery of hPBMCs instigates early-stage humanized DTC niches. Next, we challenged humanized early stage DTC niches with hPBMCs under the hypothesis that mature, functional human immune cells would decrease metastasis. After the subdermal implantation of hBMSC scaffolds for 3 weeks, 2 × 10 6 eGFP-luciferase PC3 cells were injected into the mouse prostate to form an orthotopic human prostate tumour xenograft. The primary tumour grew for 6 weeks before the intravenous injection of 1 × 10 7 hPBMCs to introduce human immune cells to the implanted microenvironments.
By this point, the host animals carried substantial primary and metastatic tumour burden. Thus, 5 days after hPBMC injection, we euthanized mice and characterized the establishment of the early humanized metastatic niche in the scaffolds (Fig. 4a ). IHS revealed the coexistence of human stromal (hVimentin), human immune (hCD45) and human tumour (hCytokeratin) cells residing in the same microenvironment ( Fig. 4b ). BLI analysis of explanted scaffolds revealed 8% of scaffolds produced a positive signal from both control (3 out of 36) and hPBMC (4 out of 44) injected mice. There was no significant difference in the overall bioluminescent signal intensity between hPBMC-injected and control mice ( Fig. 4c ). We expected that hPBMC-induced inflammation within humanized DTC niches altered DTC fate, but these results indicated that a longer period of implantation was necessary to substantiate the functional consequence.
Serial transplantation of humanized DTC niches facilitates longterm monitoring of metastatic evolution. We hypothesized that the evolution of the early humanized DTC niches could be continued by intact transplantation of the microenvironment to the same anatomical site of syngeneic mice. We followed the aforementioned experimental schedule to generate humanized DTC niches with and without hPBMCs. Bioluminescent signal from scaffolds retrieved from primary mice were checked ex vivo, and BLIscaffolds were transplanted immediately into naive NSG mice (aged 6-12 weeks). Subsequent metastatic relapse was non-invasively monitored on a weekly basis via BLI starting 4 weeks after transplantation and continued for up to 10 weeks ( Fig. 4d ). We did not observe notable necrotic tissue areas upon histological analyses of serially transplanted scaffolds (data not shown). Gross observation 3 and 7 days after transplantation showed large blood vessels surrounding the scaffolds ( Supplementary Fig. 9 ). By the end of the study, serially transplanted microenvironments captured a broad range of the metastatic cascade ( Fig. 4e ). Based on the bioluminescent intensity and outgrowth beyond the scaffold, we categorized scaffold microenvironments into the following three groups: BLI -; BLI + ; and Overt. BLI + microenvironments were defined by a signal that was at least three times greater than the background signal, and the rest were defined as BLImicroenvironments. The background BLI signal was determined from mice that were not injected with luciferin. Overt growth, a subcategory of BLI + , described aggressive metastases, whereby the tumour expanded outside the boundary of the scaffold (Fig. 4f ). hPBMC-free mice displayed a gradual increase in the number of BLI + scaffolds over the 10-week period, whereas in mice with hPBMCs, the number of BLI + scaffolds stabilized 8 weeks after transplantation. By the end of the study, 53% (17 out of 32) and 23% (9 out of 40) of scaffolds became BLI + in hPBMC-free and hPBMC-injected mice, respectively. There was no significant difference in the percentage of scaffolds with overt metastasis between the two groups; 6.3% (2 out of 32) in hPBMC-free and 10% (4 out of 40) in hPBMC-injected mice. Our results signify the ability of hPBMCs to suppress human DTC growth while not affecting the incidence of aggressively growing metastases.
Complete optical sectioning of BLIscaffolds captures the impact of hPBMCs on early DTCs.
We hypothesized that BLIscaffolds still attracted CTCs, but the number of DTCs were low and the cells entered a dormant state. Conventional IHS and flow cytometry may not effectively detect rare DTCs due to the technical difficulties of probing entire tissue volumes and representative cell recovery after tissue digestion, respectively. To overcome these challenges, we adapted the recently introduced CLARITY technique through which optically cleared fixed tissues enable detection of rare cell populations while retaining spatial resolution in the tissue microenvironment via optical microscopy 63 (Fig. 5a ). A polyacrylamide hydrogel meshwork (4 wt%) was formed between fixed cellular proteins before removal of light-scattering lipids, achieved by passive washing with sodium dodecyl sulfate and boric acid at 37 °C. Transparency dramatically improved in the scaffold, but light scattering was still present, possibly due to ICC geometry or a mismatched hydrogel density between the pore cavities and scaffolds ( Fig. 5b) . We cut the scaffolds to a thickness of 250 µ m using a cryostat, which allowed complete optical imaging ( Fig. 5c ). Sliced scaffolds were stained with antibodies for mouse α -smooth muscle actin and human cytokeratin to visualize the vasculature and tumour cells, respectively. Analyses of the images revealed abundant (80-400) single DTCs as well as a few colonized DTCs throughout the BLIscaffolds ( Fig. 5d ; Supplementary Video 1). DTCs were detected in all characterized BLI -(6 out of 6) scaffolds regardless of hPBMC injection. Complete counts of single and colonized DTCs did not show a significant difference between hPBMC-injected and hPBMC-free mice ( Fig. 5e ). A further spatial analysis revealed the widespread distribution of DTCs across inner and outer regions of the scaffolds ( Supplementary Fig. 10 ). The frequency of colonized DTCs in total tumour counts was two times higher in implants with hPBMCs compared with hPBMC-free implants ( Fig. 5f ).
There was no significant difference in DTC colony size among BLIscaffolds, with an average cross-sectional area of 3,700 μ m 2 ( Supplementary Fig. 11 ). These results suggest that the implantable pre-metastatic niches effectively attract CTCs and subsequently maintain the long-term viability of DTCs. hPBMC injection disrupted DTC survival but did not decrease colonization events. We then extended the cytological profiling of the DTCs to determine intrinsic tumour cell properties and proliferative state using standard IHS. First, we examined CD44 expression in DTCs to identify potential cancer stem cells 64, 65 . Approximately 29% of primary tumour cells (n = 3 primary tumours) co-expressed hCD44 and hCytokeratin whereas all observed DTCs (97 DTCs from 4 independent scaffolds) were double positive regardless of being in single or colonized states ( Supplementary Fig. 12 ). To confirm cellular dormancy, we examined the functional status of the DTCs. Several studies have reported a subset of markers that are expressed while DTCs are in a dormant state; however, these markers have been shown to be dependent on the microenvironment [66] [67] [68] [69] . For example, although NR2F1 was shown to promote dormancy in the lung and spleen, it does not play the same role in DTCs found in the bone marrow 70 . Additionally, the expression of these markers is transient and relative; therefore, they are not necessarily informative to distinguish the functional state of dormancy [71] [72] [73] . Thus, we focused on expression of the cell proliferation marker Ki67. All singular DTCs found in the scaffold microenvironments (n = 107) were Ki67 -, confirming that these cells were not in a proliferative state. In DTCs that formed colonies, only 8.3% (24 out of 252) contained at least one Ki67 + cell. We did not observe any colonies in which all cells expressed Ki67. These results suggest that the majority of initial proliferating DTCs stop growing and enter dormancy, indicating that intrinsic properties of early DTCs may be important to initiate metastatic colonization but not sufficient to lead to continuous growth. Comparison between scaffolds with and without hPBMCs revealed no significant differences in the number of Ki67 + DTCs (Fig. 5g ).
Comparative analyses of niche factors identifies key microenvironmental regulation of DTCs in single-to-colony transition.
Next, we characterized how early DTC niches evolved by probing the local tumour microenvironments in single and colonized DTCs. By leveraging the uniform pore geometry of the scaffold, we generated a standardized imaging analysis of the microenvironment ( Fig. 6a ). Antibodies for IHS were chosen to determine the role of blood vessels (mCD31), human stromal cells (hVimentin), human immune cells (hCD45) and innate mouse immune cells in the single-to-colony transition of DTCs. Snapshots were collected in the tumour microenvironment of single cell and tumour colonies from at least four independent scaffolds ( Fig. 6b ). We first determined the proximity of human immune cells to single and colonized DTCs. hCD45 + cells were located significantly closer to colonized DTCs, and ~25% of tumour colonies were infiltrated with hCD45 + cells. However, colocalization of a single tumour cell and human immune cell was rare ( Fig. 6c ). Next, we analysed the correlation between single and colonized DTCs with respect to the distance from blood vessels. In general, blood vessels were found within 50 µ m of a tumour cell. Without hPBMCs, over 50% of tumour colonies had at least one infiltrating blood vessel, but this phenomenon was observed in less than 35% of tumour colonies in scaffolds with hPBMCs ( Fig. 6d ). As expected, the average colony size infiltrated with blood vessels was significantly larger than those without, but there was no significant correlation between tumour colony size and hPBMCs ( Fig. 6e ). Functional characterization between Ki67 + tumour colonies and blood vessel availability revealed that nearly all (8 out of 9) proliferative colonies had infiltrating vasculature. However, infiltrating vasculature did not guarantee proliferation, only accounting for 23% (8 out of 35) instances. These observations were not dependent on the presence of hPBMCs ( Supplementary Fig. 13 ).
We extended the quantitative analysis of IHS images with other microenvironmental components. First, the distance between tumour cells and blood vessels was considered when in the proximity of hBMSCs. Although the existence of DTCs and hBMSCs in the same pore was rare, as the cellularity of hBMSCs decreased over the implantation period, tumour colonies that formed near hBM-SCs were more likely to be infiltrated with a blood vessel than those not closely associated with human stroma (Fig. 6f ). Next, we characterized the recruitment and distribution of endogenous mLy6G + , mLy6C + and mF4/80 + cells to determine the role of innate immune cells. Abundant mLy6C + and mF4/80 + cells were observed at the pore periphery in nearly every pore regardless of experimental condition, indicating that their response was dominantly triggered by the biomaterial rather than tumour or human immune cell activities ( Supplementary Fig. 14) . Both mLy6C + and mF4/80 + cells are known critical players in tissue remodelling, secreting protease enzymes including matrix metallopeptidase 9 (MMP9) 74 . IHS of MMP9 confirmed localized tissue remodelling activity at the pore surface ( Supplementary Fig. 15 ). Interestingly, mLy6G + cells were preferentially localized within tumour colonies compared to single DTCs (Fig. 6g ). The distribution of mLy6G + cells in tumour colonies was independent of their proliferative status, as confirmed by Ki67 staining (Supplementary Fig. 16 ). Taken together, these results indicate that increasing vascular connection and recruitment of mLy6G + cells are common and could be important changes in DTC niches during single-to-colony transition.
Multiplex IHS of overt metastasis substantiates the importance of innate immune cell influx in the continuous outgrowth of DTCs. To understand how the early DTC microenvironment evolved during metastatic relapse, we characterized tumours that had progressed beyond the initial awakening events. A panel of nine different antibodies-hCytokeratin, hVimentin, mCD31, hCD45, Ki67, hCD4, hCD8, mLy6G and mF4/80-and the nucleus stain Table 1 ). Eight consecutive histological sections, 20-µ m thick, were stained with sets of 3-5 antibodies to generate a multiplexed and comprehensive view of the heterogeneity in a metastatic tumour ( Supplementary Fig. 17 ). Using ImageJ, individual image channels were centred and overlaid. From these cumulative images, eight zones were manually identified that highlighted regions of diversity (Fig. 7a ).
To quantitatively determine the cellular and functional signatures of each zone, we developed an imaging analysis pipeline. Two different characterizations were considered for quantifying the selected regions ( Supplementary Fig. 18 ). The first analysis compared the absolute pixel number of each stain within each zone to highlight the make-up of each region, which was displayed as a bar graph. The second was a comparative analysis between zones, which was plotted on a radial chart broken into the following two panels: a general overview of cellularity and the diversity of immune cells (Fig. 7b ). A comparison of the different zones revealed similar phenotypes that were categorized into five separable regions. Zone 1 highlighted a typical necrotic tumour region consisting largely of weak signals of human tumour and immune cell markers. Mouse macrophages were present but relatively low compared to other regions. A pocket of mouse tissue, zone 4, was characterized by a low signal of human cell markers and a weak Ki67 signal. Zones 5 and 6 exhibited similar tissue microenvironments to that of a dormant DTC niche; a high number of human stromal and immune cells with relatively few mLy6G + cells were observed, and the overall Ki67 signal was weak. On the periphery of the scaffold, zones 7 and 8, an increase in vessels and immune cells was observed (Fig. 7c) . In contrast to our observation of micrometastases, the frequency of human immune cells in overt tumour regions was significantly lower (Fig. 7d ). This result was possibly caused by a reduction in human immune cells, but IHS of spleens revealed the presence of hCD45 + cells, suggesting that a subset of human immune cells systemically migrate and proliferate in the secondary host. The frequency of hCD45 + cells in the spleen was not significantly different between secondary mice with and without overt tumours ( Supplementary Fig. 19 ). Zones 2 and 3 contained actively growing tumours, as indicated by high DAPI and Ki67 staining. Zone 2 had a higher hCytokeratin signal than in zone 3, but only half the relative Ki67. High hVimentin in zone 3 suggested a more mesenchymal tumour phenotype, which was linked with higher proliferation compared with the more epithelial tumour phenotype in zone 2. A colocalization analysis confirmed that Ki67 staining was mostly derived from tumour cells and not mLy6G + cells that were also observed in these actively growing tumour zones (Fig. 7e ). mLy6G + cells limitedly infiltrated overt tumour regions and remained on the tumour periphery, opposite to what was observed during the early stages of colonization ( Fig. 7f ). Considering the relatively short lifespan of mLy6G + cells, ~1 day 75 , this result indicates that mLy6G + cells continuously migrated to actively growing tumours. This phenomenon was repeatedly observed in three independent overt metastatic tumours ( Supplementary Fig. 20 ). Together, these results demonstrate that the tumour microenvironment evolves during the progression to an overt tumour, including phenotypic changes of tumour cells to a more mesenchymal phenotype and a continual recruitment of innate immune cells, especially mLy6G + cells.
discussion
Accumulating evidence suggests that systemic spread of DTCs may be unavoidable 76 , but metastatic relapse can be preventable. For example, low-dosage aspirin 77 , canakinumab 78 , metformin 79 and cabozantinib 80 can significantly reduce the risk of metastasis. It is imperative to develop a detailed understanding of how these molecules suppress the revitalization of dormant DTCs in distant tissue sites. The lack of relevant experimental models that can faithfully determine the long-term functional consequence of therapeutic intervention in the context of humanized tissue microenvironments has been a critical challenge. The presented tissue engineered premetastatic niche model represents a new opportunity to study the post-dissemination phase of human cancer biology from three distinct aspects. First, the use of biomaterials to create a pre-metastatic niche enabled controlled and analytical experimentation to quantitatively distinguish key features of microenvironmental regulation in the dormant-to-active transition of DTCs. The standardized structure of ICC scaffolds generated reproducible tissue microenvironments and streamlined multiplex imaging and comparative analysis of DTC niches. Additionally, optical transparency of polyacrylamide hydrogels enabled whole-tissue clearing and complete optical sectioning of tumour microenvironments to detect rare DTCs while retaining spatial resolution. Implantation of biomaterials in a subcutaneous pocket enables easy accessibility to various functional characterizations, including direct measurement of tumour growth, BLI and possible intravital imaging via surgical engraftment of a skinfold window chamber 37, 81 . The tunable design of ICC hydrogel scaffolds allows easy manipulation of physical and geometrical parameters. Recently, there has been substantial progress in the understanding of the interaction between implantable biomaterials and host tissue and immune cells 82 . For example, poly(lactic-co-glycolic acid) scaffolds 83 and methacrylated alginate cryogels 84 manipulate dendritic cell homing and immune response. Meanwhile, scaffolds composed of extracellular matrix proteins have modulated pro-regenerative systemic immune environments 85 , and physical dimensions of biomaterials influenced foreign body response 86 . These efforts can further empower an implantable premetastatic niche model to study human tumour metastasis. Second, in vitro seeding of stromal cells provided the additional capability of creating defined and functional implantable pre-metastatic niches. Here, hBMSCs were introduced into the scaffold to create a humanized stromal niche and to modulate foreign body responses and inter-scaffold angiogenesis. hBMSCs are known to secrete immunomodulatory and pro-angiogenic molecules, which have resultantly attenuated the foreign body response 87 and enhanced angiogenic activity 37 in previous studies. Similarly, different types and combinations of stromal cells can be introduced into biomaterials to induce defined functionalities within the of microenvironments. For example, genetically engineered stromal cells that secrete specific human cytokines were used to create defined humanized soluble microenvironments 88 .
Finally, the transplantation strategy separated early metastatic niches from advanced tumours and prolonged the microenvironment evolution to substantiate functional mechanisms behind metastatic relapse. Serial transplantation has been commonly conducted to maintain the intrinsic characteristics of human blood cancer cells and solid tumours (for example, patient-derived xenograft tumours) in the context of a living system for extended periods 89, 90 . Applying this concept to metastatic tumour microenvironments overcame the fundamental limitation of mouse models for studying the long-term evolution of the DTC niche beyond the lifespan of primary host mice, and enabled the observation of the full spectrum of post-disseminated tumour progression. Here, we exploited this feature to determine the functional consequence of acute inflammation triggered by hPBMC injection. Even though the experiment was halted 10 weeks after transplantation, dormant DTC microenvironment studies could continue for longer experimental durations. This capability will facilitate observations of the long-term dormant DTC niche and the screening of drugs for metastasis prevention.
Intravenous injection of hPBMCs instigated early humanized DTCs niches, and subsequent metastatic relapse became evident 6 weeks after serial transplantation. The progression of early metastatic niches was significantly lower and stabilized compared to hPBMC-free scaffolds. This phenomenon is reminiscent of a graftversus-tumour response 46, 91, 92 . The comparative analysis of single and colonized DTCs revealed a correlation between human immune cells and colonized DTCs, whereas single DTCs did not directly interact with human immune cells (Fig. 6c,d) . Given the observation of reduced numbers of DTCs in mice that received hPBMCs, direct contact between human immune and tumour cells could be a potential mechanism in the elimination of DTCs. Indeed, a previous study has shown that the systemic delivery of hPBMCs before the subcutaneous injection of human PC3 tumour cells in NSG mice significantly decreased ectopic tumour development with increased primary tumour infiltration of T lymphocytes 93 . Additional studies have reported that T lymphocytes within patient-derived xenografts continually proliferated and systemically spread to the host NSG mouse 94 . Similarly, we confirmed the presence of hCD45 + cells in the spleens of secondary mice, indicating that a subset of human immune cells migrated out from the scaffolds and potentially continued growth. This could be the mechanism that leads to long-term stabilization of DTC growth in secondary hosts. Although hPBMCs reduced the incidence of overall metastatic relapse, the incidence of developing overt metastasis was unchanged. Additionally, complete optical sectioning of BLIscaffolds revealed an increased frequency of colonized DTCs in total DTC counts in mice that received hPBMCs (Fig. 5f) . These results suggest that although hPBMCs decreased DTC burden, during this process they may also increase the chance to initiate colonization of DTCs, possibly due to local tissue inflammation. However, detailed mechanisms by which human immune cells promoted colonization of DTCs remains an open question.
Previous studies have highlighted vasculature and immune cell interaction as critical for the reactivation of dormant DTCs 10,95-99 . Our results provide additional evidence to support these findings and quantitatively capture the changes in the local DTC microenvironments from single to colonized to overt metastasis. The vasculature is initially used by tumour cells to migrate to distant tissues; however, during the period of dormancy, DTCs remain distant from the vasculature. The quantitative analysis of the blood vessels surrounding DTCs revealed that tumour cells begin to proliferate without immediate contact with a blood vessel, but their growth could not exceed a cross-sectional area of ~4,000 µ m 2 without the connection to a blood vessel. It remains unclear whether DTCs migrate towards a blood vessel, a vessel is recruited by DTCs or DTCs and vessels meet opportunistically. Recent studies have suggested that the source of angiogenic signalling may be derived from local immune and stromal cells that release proinflammatory or proangiogenic factors that initiate endothelial tip cell sprouting 10, 100, 101 . Alternatively, they may induce phenotypic switching of perivascular cells to a less differentiated state 102 or transiently enhance vascular remodelling activity.
Additionally, our results substantiate the important role of continuously recruited innate immune cells in forming a supportive microenvironment for awakening dormant DTCs. mLy6G + cells consist of several myeloid cells, including monocytes, granulocytes and neutrophils. Recent studies have shown that neutrophils are associated with playing a key role in initiating metastatic outgrowth [95] [96] [97] [98] [99] . Deep optical characterization of the metastatic niche demonstrated their presence within awakening DTC colonies during initial tumour colonization. However, it is unclear how the host neutrophils seek out early-stage, reactivated DTCs and their role in promoting or inhibiting growth. Once a tumour colony became an advanced overt metastasis, mLy6G + cells no longer infiltrated but remained on the periphery where they were continually recruited. The lack of infiltrating neutrophils within overt tumours indicates that the tumour may produce a repulsive microenvironment once it has formed a large enough mass. The varying activities of mLy6G + cells within the different stages of tumour development demonstrate the need for a deeper understanding of myeloid cell biology, such as neutrophils in the tumour microenvironment, which may lead to more effective anti-metastatic strategies 103 . It is possible that many budding metastases fail to evade immune response at the initial stages of outgrowth and become terminated. Tumours that can evade microenvironmental control will continue to proliferate and gain control of the microenvironment and dictate bidirectional interactions with surrounding cells. From our data, we demonstrated that overt tumour cell proliferation occurs together with vascularization and exclusion of innate and adaptive immune cells, while selectively attracting a subset of innate immune cells to the actively proliferative boundary, allowing for continuous growth (Fig. 8) .
The presented implantable pre-metastatic niche model has enabled detailed observation of awakening dormant DTCs in vivo; however, there is room for improvement. First, since the established humanized microenvironments comprise three different donors, human immune interactions are allogeneic, which limits the study of adaptive immune system-mediated tumour microenvironment regulation. Creating donor-matched microenvironments is possible by obtaining different tissue cells from the same patient, but this involves clinical and ethical considerations 104 . An alternative solution is to use induced pluripotent stem cells that can differentiate into stromal, haematopoietic and tumorigenic cells 105 . While the current study has focused on humanized tumour microenvironments because of the translational opportunity, for mechanistic studies, the experimental system could be adapted to an entirely mouse-based model. Second, hPBMC injection delivers fully functional human immune cells, but the innate immune cell effect is restricted to a short-term period due to their limited lifespan; the average lifespans of monocytes and neutrophils are ~1 week and 24 h, respectively 75, 106 . Instead, repeated injection of human granulocytes into the humanized mice could replenish short-lived immune cells. Alternatively, the transplantation of human haematopoietic stem cells could stably provide human innate immune cells, but differentiated human immune cells in the mouse bone marrow may not carry full functionality 107 . Emerging data, including our own, have demonstrated that innate immune cells play a critical role in regulating the tumour microenvironment [108] [109] [110] . Innate immune cell activity does not strictly rely on the highly specific binding required for adaptive immune cells; therefore, human tumour and mouse innate immune cell interaction may be clinically relevant. Third, the prolonged local foreign body response unnaturally elevated macrophage activity and may not accurately reflect physiological situations. Recent studies have shown that locally implanted biomaterials modulate systemic immune responses and host regenerative potential 85, 111, 112 . Additionally, biomaterial-induced myeloid cell responses were shown to be tunable by incorporating macrophageselective drugs; for example, clodronate for macrophage depletion 81 . Finally, transplantation of the intact microenvironments possibly caused brief temporal oxygen and nutrient deprivation. Aside from intrinsic changes to DTCs, their fate can be critically influenced by the secondary host cells, especially immune cells. We minimized this potential effect by using syngeneic mice and implanted the microenvironments into the same anatomical locations. However, a similar clinical scenario has been reported in the field of organ transplantation whereby dormant DTCs in the donor organ developed metastasis in the recipient 113, 114 . Indeed, this feature may provide a new opportunity to investigate the role of local and systemic tissue microenvironments by altering the recipient host animal in terms of age, immune competence and implantation site.
Mouse models play a critical role in advancing our understanding of cancer metastasis; however, their capability of capturing the long-term evolution of the metastatic niche and their relevance to humans remains questionable. Tissue engineered humanized metastasis models can reduce the preclinical gap and potentially uncover new biological interactions between human tumours and the surrounding microenvironment. Studies can be readily extended to characterize the extracellular matrix and molecular and genetic profiles. A promising future direction is to combine comparative analysis based on endpoint IHS characterization with temporal observations of cellular processes via intravital or ex vivo imaging, which will enable a deeper mechanistic understanding of DTC niche evolution. The established metastasis model can also be applied to screen the effectiveness of drugs targeting DTCs and secondary outgrowths. Taken together, we envision that tissue engineered strategies will provide an invaluable tool to answer provocative hypotheses emerging in the cancer field and advance the clinical translation of antimetastatic therapeutic strategies.
methods
All chemicals and materials were purchased from Sigma Aldrich or Fisher Scientific unless specified. All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Massachusetts-Amherst. Experiments and handling of mice were conducted under federal, state and local guidelines.
Type I collagen-coated ICC hydrogel scaffold fabrication. ICC hydrogel scaffolds were fabricated following previously reported methods 37 . Soda lime glass beads were sorted using an Advantech Sonic Sifter for each range with ~8% deviation. Beads dispersed in deionized water were gradually loaded into a glass vial (8 × 35 mm) to a height of 2-2.5 mm and were mechanically packed into a lattice structure in an ultrasonic water bath. Orderly packed glass beads were dried in a 60 °C oven and then thermally annealed for 4 h in a furnace between 650 and 680 °C depending on the bead size. A hydrogel precursor solution composed of 5, 15, 30 and 50 wt% acrylamide monomer, 1.5 wt% bis-acrylamide crosslinker, 0.2 vol% N,N,N′ ,N′ -tetramethylethylenediamine accelerator, and 0.2 vol% 2-hydroxy-2-methylpropiophenone photoinitiator in nitrogen-purged deionized water was prepared immediately before use. Precursor solution (150 µ l) was infiltrated into the glass bead template and centrifuged in a microcentrifuge at 4,000 g for 15 min and subsequently polymerized under a 15 W ultraviolet light source for 15 min. Polyacrylamide hydrogel-glass templates were removed from the glass vials the next day to ensure complete polymerization. Excess hydrogel was removed by scraping the glass bead template with a razor blade on all surfaces. Glass beads were selectively dissolved in alternating washes of an acid solution containing a 1:5 dilution of hydrofluoric acid in 1.2 M hydrochloric acid and 2.4 M hydrochloric acid (caution: these chemicals are corrosive and must be used in a fume hood with proper protective gear). Washes were completed on a shake plate, and solutions were changed every 4 h until the beads were removed. Scaffolds were thoroughly washed with deionized water to remove residual acid and lyophilized. Following lyophilization, scaffolds were resuspended in Cryomatrix embedding resin and cut to 1-mm thickness using a CryoStar NX70. After thorough washing in deionized water, scaffolds were sterilized with 70% ethanol and stored at 4 °C in sterile phosphate buffered saline (PBS) solution. The final pore dimension of the optimized scaffolds used for the remainder of the study was 300 ± 16 µ m. To support stromal cell adhesion on polyacrylamide hydrogel scaffolds, type I collagen extracted from rat tails was covalently immobilized on the pore surface using Sulfo-SANPAH conjugate chemistry ( Supplementary Method 1) .
Human BMSC isolation and culture expansion. Bone marrow aspirate (50 ml) obtained from a healthy donor was purchased from Lonza. Mononuclear cells were isolated via density gradient-based centrifugation using Ficoll Paque (GE Healthcare) at 300 g for 30 min using minimum acceleration and no brake. Mononuclear cells were plated on T-225 flasks with Minimum Essential Medium Eagle, alpha modified (α MEM) supplemented with 20% FBS, 2% penicillinstreptomycin, 0.2% gentamicin and 1 µ g per litre recombinant human fibroblast growth factor. After 1 week, colonies of adherent cells were collected, cryogenically frozen in media containing 10% dimethylsulfoxide (DMSO) and stored in a cryotank. The multilineage differentiation potential of hBMSCs was tested using standard protocols (Supplementary Method 2).
Human BMSC seeding and culture on a 3D hydrogel scaffold. Collagen-coated ICC hydrogel scaffolds were partially dehydrated by removing excess PBS and drying in a biosafety cabinet. hBMSCs (5 × 10 5 ) suspended in growth media (20 µ l) were dropped on top of a partially dehydrated scaffold. The cell suspension was drawn into the dried scaffold, facilitating deep and homogenous cell seeding in the three-dimensional (3D) scaffolds. Cell-loaded scaffolds were incubated for 20 min in a CO 2 incubator to allow initial cell adhesion. Cell scaffolds were transferred to a 48-well plate containing 500 µ l of media and allowed to grow for up to 1 week before use. Medium was changed every 3 days.
Subdermal implantation of hBMSC scaffolds in NSG mice.
A breeding pair of NOD-scid IL2Rg null mice (005557) was initially obtained from Jackson Laboratories. NSG mice were housed in sterile conditions with unrestricted access to food and water. In this study, 6-13-week-old mice were used for implantation. Mice were anaesthetized with 1.5% isoflurane and dorsal hair was removed with electric clippers and Nair. The skin was sterilized using 70% isopropyl alcohol prep wipes. Prior to surgery, meloxicam (2 mg per kg mouse weight) was subcutaneously injected. Horizontal incisions (2 mm) were made in the upper and lower dorsal spaces. A subcutaneous pocket was formed by inserting surgical scissors into the incision and expanding. One scaffold per subcutaneous pocket was implanted, and the incisions were closed with two Reflex 7-mm wound clips. Four scaffolds were implanted per mouse. Wound clips were removed after 1 week.
Characterization of cytokine secretion of implanted hBMSC scaffolds.
Implanted hBMSC scaffolds were retrieved at 4 and 12 weeks from NSG mice. Explanted scaffolds were cut into 1-2-mm pieces using surgical scissors and cultured in 500 µ l of α MEM media supplemented with 1% mouse serum and 1% penicillin-streptomycin for 36 h. For control samples, 1 week in vitro cultured hBMSC scaffolds were used. Conditioned medium was collected and used immediately for characterization of human VEGF, IL-6 and IL-8 secretion using DuoSet ELISA kits (R&D Systems).
Tail vein injection of human PBMCs. Whole blood was obtained from three healthy male donors (aged 20-38 years) in BD Vacutainer K2 EDTA blood collection tubes. Mononuclear cells were isolated via density gradient-based centrifugation using Ficoll Paque at 300 g for 30 min using minimum acceleration and no brake. From ~30 ml of whole blood, 25-30 million PBMCs were extracted. Isolated mononuclear cells were counted and re-suspended in PBS to a density of 10 × 10 6 or 20 × 10 6 cells per 100 µ l PBS. Scaffold-bearing mice with and without tumour were warmed under a heat lamp to dilate the tail vein, placed in a restrainer, and PBMCs were intravenously delivered by tail vein injection using a 27-gauge needle.
Human PBMC distribution and cytokine secretion. Mice 6-13 weeks of age were implanted with hBMSC-seeded scaffolds. hPBMCs (20 × 10 6 ) suspended in 100 µ l of PBS were intravenously delivered 5.5 weeks after scaffold implantation. Mice were euthanized 24 h after hPBMC injection. Lung, liver, spleen, bone and scaffolds were retrieved. Tissue samples were aliquoted for analysis via flow cytometry or ELISA. For flow cytometry experiments, freshly collected tissue samples were minced with scissors in a 40-µ m cell strainer and further digested with collagenase, type II. Stock solution (100 U µ l -1 ) was diluted in PBS to 200 U ml -1 and added to the tissue for 15 min. Tissue pieces were pushed through the 40-µ m cell strainer using the back of a 1-ml syringe plunger. DMEM medium containing 10% FBS was added to quench the enzymatic reaction before spinning down in a centrifuge at 300 g Cell pellets were resuspended in fluorescence-activated cell sorting (FACS) buffer (PBS containing 1% bovine serum albumin (BSA)) and counted. Cells were spun down again and resuspended to a final concentration of 1 × 10 7 cells ml -1 in FACS buffer. The cell suspension (100 µ l) was added to a U-bottom 96-well plate. FACS buffer (100 µ l) containing 2.5 µ g of Fc Block was added to each well and incubated for 10 min at room temperature. The plate was spun down and supernatant removed before adding mouse anti-human CD45-PE diluted in FACS buffer 1:100. Samples were incubated for 30 min at room temperature in the dark. Samples were washed three times with FACS buffer before being transferred to FACS tubes and analysed with a BD LSRFortessa. BD FACSDiva software was used for both collection and analyses. For human cytokine secretion, retrieved tissues were kept relatively equal in size and cut into 1-2-mm pieces using surgical scissors. Conditioned medium was prepared 36 h after plating in 500 µ l of α MEM 26 . eGFPluciferase PC3 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Scaffold-bearing mice were anaesthetized with 2% isoflurane followed by ventral hair removal with Nair. Skin was sterilized with 70% isopropyl alcohol prep wipes. Before surgery, meloxicam (2 mg per kg mouse weight) was subcutaneously injected. A 10-mm vertical incision was made in the lower abdomen of the mouse. The bladder was externalized through the opening to expose the prostate. eGFP-luciferase PC3 cells (2 × 10 6 ) suspended in 50 µ l of matrigel were injected into the prostate using a 27-guage needle. The bladder was returned to the intraperitoneal cavity, the muscle layer was sutured using polyglycolic acid sutures (Henry Schein), and the skin was clamped with Reflex 7-mm wound clips. Clips were removed after 1 week.
Monitoring human tumour engraftment and metastasis by BLI. Two weeks after orthotopic injection of Luciferase-GFP PC3 tumour cells, whole-body BLI was performed to confirm engraftment and metastasis to distant organs using an IVIS SpectrumCT (Perkin Elmer). Luciferin was prepared by dilution in PBS to a concentration of 15 mg ml -1 in PBS. Mice were anaesthetized with 2% isoflurane and injected intraperitoneally with 10 µ l luciferin solution per g of body weight before being placed in the imaging chamber. Images were taken every 5 min until peak values were achieved. Six weeks after orthotopic tumour injection, mice were euthanized, and scaffolds were retrieved and placed in a 48-well plate. Luciferin stock solution was diluted 1:100 in PBS and 300 µ l was loaded into each well. BLI was performed every 2 min until peak values were obtained.
Non-invasive long-term monitoring of metastasis in serially transplanted scaffolds. Metastatic tumour microenvironments primed in primary mice were retrieved and immediately transplanted to the same anatomical site in naive male NSG mice (6-12 weeks old) following the same method as initial scaffold implantation. Wound clips were removed after 1 week. Whole-body BLI was started 4 weeks after serial transplantation and continued for an additional 6 weeks, with measurements taken weekly. Images were taken every 5 min until peak values were achieved.
Scanning electron microscopy imaging. Microfabricated scaffolds coated with type I collagen were fixed with 2% glutaraldehyde, serially dehydrated with 50, 70, 90 and 100% ethanol and lyophilized overnight. The prepared dehydrated samples were deposited with a thin gold film using a sputter-coating machine (208HR; Cressington) and observed using a Zeiss Ultra55 field emission scanning electron microscope.
IHS and imaging.
At the end of in vivo experimentation, tissue and scaffold samples were frozen by embedding tissue in Cryomatrix and snap-frozen in a metal beaker containing 2-methylbutane cooled by dry ice. Frozen samples were sectioned using a Cryostat (NX70). Scaffolds were cut to 20-25 µ m, while native tissue samples were cut to 10-µ m thickness and attached to ColorMark Plus glass slides. Remaining frozen tissue blocks and sectioned slides were stored at − 80 °C. Frozen tissue was briefly fixed in pre-chilled acetone for 10 min. Following three wash cycles in 0.05% Tween-20 in PBS (PBST), samples were outlined with a hydrophobic marker and blocked with 10% goat serum and 1% BSA in PBST for 2 h at room temperature. Primary antibodies were added at a dilution ratio of 1:200 in blocking solution and left overnight in 4 °C. Samples were washed three times with 0.05% PBST followed by secondary antibodies at a dilution ratio of 1:200 in blocking solution and left for 2 h at room temperature. Samples were washed three times with PBST before the addition of 1 µ g ml -1 DAPI solution and a cover slide. When required, streptavidin-conjugated Qdot was added to the samples and left for 1 h before the final washing cycle. DAPI solution (10 µ l of 10 ng µ l -1 ) was added to samples before imaging. Images were obtained using a Zeiss Cell Observer SD with × 10x and × 20 objectives. Tiling was performed with 10% overlap. Human antibodies were validated against relevant mouse tissue to rule out cross-reactivity ( Supplementary Fig. 21 ). For haematoxylin and eosin and trichrome staining, frozen tissue sections were fixed with 10% neutral buffered formalin for 10 min. After washing with deionized water, slides were stained with dye solutions following the protocol provided by the manufacturer (American Master Tech) ( Supplementary Method 3) .
Optical tissue clearing and complete optical sectioning of the scaffolds. Mice were transcardially perfused with 20 ml of ice cold PBS followed by 20 ml of ice cold monomer solution containing 4% acrylamide, 0.05% bis-acrylamide, 0.25% VA-044 (thermal initiator) and 4% paraformaldehyde in PBS. Tissue samples were collected and incubated in fresh monomer solution at 4 °C for 48 h. Air in the tubes was replaced with nitrogen gas before incubation at 37 °C for 3-4 h to polymerize the monomer solution. Excess polymer was removed and samples were left in either PBS or tissue-clearing solution (4% SDS, 200 mM boric acid, pH 8.5). Scaffold samples required thick sectioning to achieve whole-tissue imaging. Samples were frozen in Cryomatrix and cut to a thickness of 250 µ m with a cryostat for a total of 4 slices per scaffold. Sections were washed thoroughly in 0. The background signal of each individual channel was removed before measuring the pixel density. Values were normalized by the zone area and the signal measured from the entire scaffold to generate a relative distribution across the scaffold. The same analysis was performed for hCD45 distribution in hPBMC-injected mice 6 weeks after intravenous injection. Percentage coverage (mCD31, hCD44, hCD45, Ki67 and mLy6G) was calculated by measuring the overlap between the positive signal and the total area of the appropriate tissue (entire scaffold, hCytokeratin or mLy6G + ). For in-depth characterization of the local tumour microenvironment, single cell and tumour colonies were manually identified by examining tiled images of stained tissue sections. Nearest vessel, vessel diameter, tumour colony diameter and nearest cell distance were measured in ImageJ for all of the identified tumour cells. Data were binned to generate histograms.
Multiple-antibody staining of overt metastatic tumour-bearing scaffolds. Eight consecutive tissue slices, each 20-µ m thick, from a single scaffold were stained with multiple combinations of antibodies, totalling 11 different stains. All of the images were aligned in ImageJ. Images were then divided into a grid of 24 × 24 images and thresholded before measuring the and pixel density for each channel. The total tissue area was determined by setting a low threshold to include the background signal. Values from each individual channel were normalized by the total tissue area within each and plotted in a 24 × 24 heatmap. Ten colour images were generated by combining images from different staining combinations. From these composite images, regions of interest were manually determined to highlight heterogeneity. Regions of interest were translated to the 24 × 24 heatmaps, and pixel density was recalculated for the 8 zones. Pixel densities from each of the zones of interest were normalized to the maximum value from the eight zones. Channels that had more than one replicate were averaged together before plotting on a radar chart. The cellular composition within each zone was achieved by normalizing the absolute pixel count of each channel by the total pixel count of the zone.
Statistics. Unpaired Student's t-tests were performed for comparing the mean values between two groups. Statistical significance was determined if P < 0.05 for two-tailed analysis. All quantitative data represent the mean and the standard deviation. 
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Experimental design 1. Sample size
Describe how sample size was determined.
Sample size (mouse and implantable microenvironment) were chosen on the basis of previously published findings (Lee, J et al, PNAS 2012, Cancer Research 2014) and preliminary experiments so as to provide sufficient power (80%) for statistical comparison (5% significance).
Data exclusions
Describe any data exclusions.
No data were excluded from the study.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The reproducibility of biomaterial fabrication, implanted-tissue-microenvironment formation with human bone marrow stromal cells, and recruitment of human tumor cells generated from an orthotopic xenograft tumors were confirmed by previously published results (Lee, J et al. Biomaterials 2009, PNAS 2012, Cancer Research 2014). The impact of hPBMC on implantable metastatic tumor microenvironment was repeated two times to ensure the reproducibility of the experimental finding. We observed the comparable pattern of metastatic tumor development in these experiments. Complete optical sectioning of implantable microenvironment was performed for at least three independent scaffolds. All other characterizations including immunohistostaining were performed in at least three independent scaffolds and tissue samples to ensure experimental reproducibility.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Experimental groups (hPBMC and control PBS-injection mice) were randomized.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not relevant to our study. Implanted scaffolds in each mouse were retrieved and reimplanted to the same mouse. Surgeons knew which mice received hPBMCs and control PBS during the surgery. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons Test values indicating whether an effect is present Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Image J was used for image analysis. Nikon Elements AR v4.5 was used for 3D rendering and creation of a video. The video was annotated in Adobe Premiere Pro CC 2014 and encoded in Adobe Media Encoder CC 2014.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
The implantable hydrogel scaffolds are readily available from the authors. All other materials are available from standard commercial sources (Fisher scientific). Human fresh bone marrow aspirate is available from Lonza.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
